Recursion (RXRX): Earnings per share for the last twelve months
Recursion Pharmaceuticals (RXRX) minimizes biotech risks by utilizing supercomputers to accelerate drug discovery. The 12-month net income per share trend confirms this approach, where -0.89 represents the current value of the metric. The Inertia platform maps biological processes, attracting capital from pharma behemoths. Meanwhile, massive computing expenditures create powerful operating leverage for future large-scale technology licensing.
Comprehensive metric breakdowns and analytics for Recursion Pharma (RXRX)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Recursion Pharmaceuticals|RXRX - Long-Term Liabilities to Equity|Short-Term Debt to Capital Recursion Corp|RXRX - Aggregate Debt Obligations|Debts to Book Capitalization Recursion Pharmaceuticals, Inc.|RXRX - Company Long-Term Debts|Company Short-Term Debt Recursion|Quick Liquidity recursion.com
- earnings and multiples data:
RXRX - Net Income|Projected Future Earnings Recursion Pharmaceuticals|RXRX - P/E Multiple|Forward P/E Multiple Recursion|RXRX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Recursion Pharmaceuticals, Inc.|RXRX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Recursion|RXRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months recursion.com|RXRX - Net earnings per one share growth for the current year|Earnings growth forecast for next year Recursion Pharmaceuticals
General company analysis:recursion.com (RXRX)
The stability of Recursion Pharmaceuticals (RXRX) is driven by growing demand from major pharma behemoths for AI technologies to accelerate drug development. Analyzing the current trailing 12-month EPS allows for the adjustment of earnings to remove the impact of share issuance, helping investors distinguish the real fundamental trend from price noise and avoid purchasing an overvalued asset by benchmarking against industry metrics.
Competitors of Recursion Pharmaceuticals (RXRX)
NVIDIA Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters coreweave.com CRWV|Nebius Group NV (NBIS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months SoundHound AI (SOUN)|Earnings per share for the last twelve months Zeta Global Holdings|Earnings per share for the last 12 months PGY (Pagaya Corp)|Net earnings per share for the last 12 months AI (C3.ai, Inc.)|RZLV (rezolve.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Super X AI Technology SUPX|DNA (Ginkgo Corp) - Earnings per one share for the last 12 months|Cerence Corp - Net earnings per share (EPS TTM)|Earnings per share for the trailing year PDYN (Palladyne Corp)|VERI: Net earnings per share (EPS TTM)|Mint Inc. (MIMI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months MicroAlgo Inc|HPAI: Earnings per share for the trailing year|Earnings per share for the last twelve months LivePerson Corp (LPSN)|Net earnings per share for the last 12 months quicklogic.com QUIK|Net earnings per share (EPS TTM) SST (System1)|Net earnings per share (EPS TTM) wisatechnologies.com DVLT|Ruanyun Edai Technology Inc. - Net earnings per share (EPS TTM)|Webus International Ltd (WETO) - Net earnings per share for the last 12 months|MCRP: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cyngn (CYN)|Net earnings per share for the last 12 months YYAI|Net earnings per share (EPS TTM) MicroCloud Hologram Inc|Net earnings per share for the last 12 months MSAI (MultiSensor AI Holdings, Inc.)|Earnings per share for the last four quarters EVAX|Net earnings per share (EPS TTM) AIXI (Xiao-I Robot)|Net earnings per share for the last four quarters CXApp Corporation (CXAI)|Brand Engagement Network Inc - Net earnings per share (EPS TTM)|Gaxos.ai Inc. (GXAI) - Net earnings per share for the last 12 months|EVGN: Net earnings per share (EPS TTM)|Infobird (IFBD) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Taoping Corp|Earnings per share for the last twelve months VSAI|Earnings per share for the last twelve months Exscientia plc (EXAI)|Net earnings per share for the last four quarters foxotechnologies.com|Earnings per share for the last twelve months Vocodia Holdings VHAI|Earnings per share for the trailing year ZPTA
